ANDREONE, Pietro

ANDREONE, Pietro  

Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto  

Mostra records
Risultati 1 - 20 di 386 (tempo di esecuzione: 0.011 secondi).
Titolo Data di pubblicazione Autore(i) File
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial 1-gen-2023 Vukotic, R.; Di Donato, R.; Roncarati, G.; Simoni, P.; Renzulli, M.; Gitto, S.; Schepis, F.; Villa, E.; Berzigotti, A.; Bosch, J.; Andreone, P.
6. A randomized controlled trial of leukocytic IFN-a vs leukocytic IFN-a plus ribavirin in chronic hepatitis C resistant to a previous recombinant or lymphoblastoid IFN treatment 1-gen-1997 Andreone, P.; Cursaro, C.; Gramenzi, A.; Di Giammarino, L.; Felline, F.; Miniero, R.; Bernardi, M.
[A possibility that tubulo-glomerular retrocontrol influences renal function in toto]. 1-gen-1982 Agnoli, Gc; Andreone, P; Cacciari, M; Cariani, A; Garutti, C; Ikonomu, E; Lenzi, P.
[Catecholamine receptors and renal function]. 1-gen-1983 Agnoli, Gc; Andreone, P; Cacciari, M; Garutti, C; Ikonomu, E; Lenzi, P.
[Effects of acute changes in water balance on hydrosaluresis and on urinary excretion of prostaglandin E, in the presence and absence of a cyclooxygenase inhibitor] 1-gen-1983 Agnoli, Gc; Andreone, P; Cacciari, M; Franceschetti, F; Garutti, C.
[Sulpiride (stereoisomers, racemic) and dopamine: actions and interactions on renal circulation]. 1-gen-1984 Agnoli, Gc; Andreone, P; Cacciari, M; Garutti, C; Ikonomu, E; Lenzi, P.
[Sulpiride (stereoisomers, racemic) and dopamine: actions and interactions on renal excretion of hydro-saline]. 1-gen-1984 Agnoli, Gc; Andreone, P; Cacciari, M; Garutti, C; Ikonomu, E; Lenzi, P.
[Sulpiride (stereoisomers, racemic) and dopamine: actions and interactions on tubular reabsorption] 1-gen-1984 Agnoli, Gc; Andreone, P; Cacciari, M; Garutti, C; Ikonomu, E; Lenzi, P.
A Case of Acute Liver Failure during Ritonavir-Boosted Paritaprevir, Ombitasvir and Dasabuvir Therapy in a Patient with HCV Genotype 1b Cirrhosis 1-gen-2016 Masetti, Marco; Magalotti, Donatella; Martino, Elena; Andreone, Pietro; Scuteri, Alessandra; Zoli, Marco
A double-blind, placebo-controlled, pilot trial of thymosin alpha 1 for the treatment of chronic hepatitis C. 1-gen-1996 Andreone, P; Cursaro, C; Gramenzi, A; Buzzi, A; Covarelli, Mg; Di Giammarino, L; Miniero, R; Arienti, V; Bernardi, M; Gasbarrini, G.
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis 1-gen-2015 Biselli, M; Conti, F; Gramenzi, A; Frigerio, M; Cucchetti, A; Fatti, A; D'Angelo, M; Dall'Agata, M; Giannini, Eg; Farinati, F; Ciccarese, F; Andreone, P; Bernardi, M; Trevisani, F.
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. 1-gen-2015 Biselli, M; Dall'Agata, M; Gramenzi, A; Gitto, S; Liberati, C; Brodosi, L; Ravaioli, M; Gambato, M; Montalti, R; Pinna, Antonio Daniele; Burra, P; Gerunda, Giorgio Enrico; Cillo, U; Andreone, P; Bernardi, Mauro
A New Two-Dimensional Shear Wave Elastography for Noninvasive Assessment of Liver Fibrosis in Healthy Subjects and in Patients with Chronic Liver Disease - Eine neue zweidimensionale Shear-Wave-Elastografie zur nicht-invasiven Beurteilung der Leberfibrose bei Gesunden und bei Patienten mit chronischer Lebererkrankung 1-gen-2018 Serra, Carla; Grasso, Valentina; Conti, Fabio; Felicani, Cristina; Mazzotta, Elena; Lenzi, Marco; Verucchi, Gabriella; D'Errico, Antonietta; Andreone, Pietro
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 1-gen-2020 Stefanescu, H.; Marasco, G.; Cales, P.; Fraquelli, M.; Rosselli, M.; Ganne-Carrie, N.; de Ledinghen, V.; Ravaioli, F.; Colecchia, A.; Rusu, C.; Andreone, P.; Mazzella, G.; Festi, D.
A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis 1-gen-2016 Nevens, F.; Andreone, Pietro; Mazzella, Giuseppe; Strasser, S. I.; Bowlus, C.; Invernizzi, P.; Drenth, J. P. H.; Pockros, P. J.; Regula, J.; Beuers, U.; Trauner, M.; Jones, D. E.; Floreani, A.; Hohenester, S.; Luketic, V.; Shiffman, M.; Van Erpecum, K. J.; Vargas, V.; Vincent, C.; Hirschfield, G. M.; Shah, H.; Hansen, B.; Lindor, K. D.; Marschall, H. U.; Kowdley, K. V.; Hooshmand Rad, R.; Marmon, T.; Sheeron, S.; Pencek, R.; Macconell, L.; Pruzanski, M.; Shapiro, D.
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort 1-gen-2022 Kondili, L. A.; Monti, M.; Quaranta, M. G.; Gragnani, L.; Panetta, V.; Brancaccio, G.; Mazzaro, C.; Persico, M.; Masarone, M.; Gentile, I.; Andreone, P.; Madonia, S.; Biliotti, E.; Filomia, R.; Puoti, M.; Fracanzani, A. L.; Laccabue, D.; Ieluzzi, D.; Coppola, C.; Rumi, M. G.; Benedetti, A.; Verucchi, G.; Coco, B.; Chemello, L.; Iannone, A.; Ciancio, A.; Russo, F. P.; Barbaro, F.; Morisco, F.; Chessa, L.; Massari, M.; Blanc, P.; Zignego, A. L.
A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B. 1-gen-1996 Andreone, P; Cursaro, C; Gramenzi, A; Zavagliz, C; Rezakovic, I; Altomare, E; Severini, R; Franzone, Js; Albano, O; Ideo, G; Bernardi, M; Gasbarrini, G.
A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of non-responder patients with chronic hepatitic C 1-gen-2007 Gramenzi, A; Andreone, P; Cursaro, C; Verucchi, G; Boccia, S; Giacomoni, Pl; Galli, S; Furlini, G; Biselli, M; Lorenzini, S; Attard, L; Bonvicini, F; Bernardi, M.
A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis 1-gen-2020 Kowdley, K. V.; Vuppalanchi, R.; Levy, C.; Floreani, A.; Andreone, P.; Larusso, N. F.; Shrestha, R.; Trotter, J.; Goldberg, D.; Rushbrook, S.; Hirschfield, G. M.; Schiano, T.; Jin, Y.; Pencek, R.; Macconell, L.; Shapiro, D.; Bowlus, C. L.
A review on extrahepatic manifestations of chronic hepatitis c virus infection and the impact of direct-acting antiviral therapy 1-gen-2021 Mazzaro, C.; Quartuccio, L.; Adinolfi, L. E.; Roccatello, D.; Pozzato, G.; Nevola, R.; Tonizzo, M.; Gitto, S.; Andreone, P.; Gattei, V.